🔔🔔🔔 𝐈𝐭'𝐬 𝐡𝐚𝐩𝐩𝐞𝐧𝐢𝐧𝐠 𝐭𝐡𝐢𝐬 𝐰𝐞𝐞𝐤! 🔔🔔🔔 🥐 Join us for an exciting #LunchTalk with Dr. Rachel E. Armstrong! 🥨 🍎 Dr. Armstrong will dive into the development of ingestible sensors to monitor gut health. 📅 Date: Thursday, October 31st, 2024 🕛 Time: 11 AM 📍 Location: DKFZ German Cancer Research Center, Communication Center 2nd floor, (room K1/K2) ✨ The Lunch Talk series is a collaboration between the DKFZ Postdoc Network (PDN) and the BioMed X Institute. 🍵 This talk will be hosted by Dr. Khulan Sergelen and her team at BioMed X, team BDB: https://lnkd.in/eWJfBwZ3 Christian Tidona | Thomas Rueckle | Yvonne Stappenbeck | Mallory Grahnert #Heidelberg #DFKZ
BioMed X Institute
Biotechnologieforschung
Biomedical innovation at the interface between academia and industry
Info
BioMed X is an independent research institute located on the campus of the University of Heidelberg in Germany, with a world-wide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.
- Website
-
https://bio.mx
Externer Link zu BioMed X Institute
- Branche
- Biotechnologieforschung
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- 69120
- Art
- Privatunternehmen
- Gegründet
- 2013
- Spezialgebiete
- Biotech, research, pharma, innovation und AI
Orte
-
Primär
Im Neuenheimer Feld 515
69120, Heidelberg, DE
-
55 Church St
New Haven, Connecticut 06510, US
Beschäftigte von BioMed X Institute
-
Thomas Rueckle
-
Christian Tidona
Incurably Curious | BioMed X Institute | XSeed Labs | Building world-class innovation ecosystems for biomedical research, drug discovery and…
-
Eleonora Melzi
DVM PhD - Research Group Leader at BioMed X Institute - Immunology
-
Gorjana Rackov
BioMed X Institute | Spanish National Centre for Biotechnology CNB-CSIC
Updates
-
🥨 Join us for an exciting #LunchTalk with Dr. Rachel E. Armstrong! 🥨 🍏 Dr. Armstrong will dive into the development of ingestible sensors to monitor gut health. 𝐊𝐞𝐲 𝐡𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 🏛 Learn about the collaborative OnePlanet Research Center and their micro/nano R&D research 💊 Recently validated ingestible smartpill for human usage 💡 Sensor development and integration into the smartpill, as well as early results from the human trial ❤️ In vivo participant data from the trial to highlight the potential of the smartpill for future applications in gut health monitoring and diagnosis 📅 Date: Thursday, October 31st, 2024 🕛 Time: 11 AM 📍 Location: DKFZ German Cancer Research Center, Communication Center 2nd floor, (room K1/K2) 𝐃𝐨𝐧'𝐭 𝐦𝐢𝐬𝐬 𝐭𝐡𝐢𝐬 𝐜𝐡𝐚𝐧𝐜𝐞 𝐭𝐨 𝐥𝐞𝐚𝐫𝐧 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐢𝐧𝐠𝐞𝐬𝐭𝐢𝐛𝐥𝐞 𝐬𝐞𝐧𝐬𝐨𝐫𝐬 𝐭𝐨 𝐦𝐨𝐧𝐢𝐭𝐨𝐫 𝐠𝐮𝐭 𝐡𝐞𝐚𝐥𝐭𝐡! 🍶 The Lunch Talk series is a collaboration between the DKFZ Postdoc Network (PDN) and the BioMed X Institute. ☕ This talk will be hosted by Dr. Khulan Sergelen and her team at BioMed X, team BDB: https://lnkd.in/eWJfBwZ3 Christian Tidona | Thomas Rueckle | Yvonne Stappenbeck | Mallory Grahnert #DKFZ #WissKomm
Team BDB
https://bio.mx
-
#WelcomeToBioMedX 💐 We are happy to welcome Eileen Sutor, our new intern in team EIT – New Strategies to Enhance the #Immunogenicity of Tumors. 💐 Eileen completed her bachelor’s degree in #Biotechnology at Hochschule Mannheim - University of Applied Science. For her bachelor thesis, she worked at the Paul -Ehrlich Institute in Langen under the supervision of Zoltan Ivics where she compared several constitutive promotors in driving efficient and stable #CD19-CAR expression with the non-viral Sleeping Beauty transposition. Currently, she is studying #Human Biology at The Philipp University of Marburg with the elective focus on #Tumor Biology. 💐 Welcome, Eileen, and good luck! 💡Are you interested in #career opportunities at the interface between #academia and #industry? Take a look at the BioMed X Institute Career Space: https://bio.mx/career. Semih Akincilar
-
#WelcomeToBioMedX 🌸We are happy to welcome Alessio Di Serafino, our new research assistant in team BDB – Advanced #Biomarker Detection for Pharmacological Monitoring in the Brain 🌸Alessio is originally from Italy and holds a master’s degree in #Biomedical Engineering from Alma Mater Studiorum – Università di Bologna, where he specialized in Innovative Technologies in Diagnosis and Therapy. He has also gained international academic experience, completing mobility semesters at the University of Coimbra in Portugal, focusing on #nanobiomaterials and medical instrumentation, and at the University of Bern in Switzerland, focusing on #electronic implants. 🌸Before joining BioMed X Institute, he completed an internship as a tissue engineer at Instituto Pedro Nunes in Portugal, conducting research on #antibacterial biomaterials using electrospinning technology. Welcome, Alessio, and good luck! 💡Are you interested in #career opportunities at the interface between #academia and #industry? Take a look at the BioMed X Institute Career Space: https://bio.mx/career. Khulan Sergelen
-
BioMed X Institute hat dies direkt geteilt
12 Jahre – so lange dauert es im Schnitt von der Idee bis zum fertigen Medikament. Diesen Forschungsprozess können wir mit Digitalisierung und KI bei Sanofi erheblich beschleunigen. Wie das funktioniert, zeigten wir beim #digitalgipfel 2024 der Bundesregierung und der hessischen Landesregierung an unserem Stand und bei unserem Panel „Health X Tomorrow: KI in Forschung und Entwicklung – noch schneller zu innovativen Arzneimitteln“. „Künstliche Intelligenz ist aus der Pharmaforschung nicht mehr wegzudenken. Als innovatives Gesundheitsunternehmen setzen wir KI bereits seit Jahren erfolgreich für die Forschung und Entwicklung neuer Medikamente ein“, sagte Dr. Marion Zerlin, Geschäftsführerin Forschung und Entwicklung, im Panel. Auf unserem Frankfurter #BioCampus setzen wir auf digitalisierte Forschungsmethoden: von KI-gestützter Forschung, Hightech-Forschungsanlagen, über neue Technologien bis hin zur Schulung von medizinischem Personal: 👉In unserer Forschungsabteilung arbeiten wir unter anderem mit KI und 3D-Brillen bei der Entwicklung von Wirkstoffkandidaten. 👉KI-gestützte, „virtuelle Patienten“ helfen uns dabei, die Wirksamkeit von neuen Medikamenten vorherzusagen und dadurch schneller vielversprechende Arzneimittelkandidaten zu finden. 👉Pneumolog*innen können in ihrer medizinischen Fortbildung mittels Augmented-Reality-Brillen Einblicke in die Lungenerkrankung COPD erhalten. Besucher*innen an unserem Stand hatten die Gelegenheit, unsere innovativen 3D- und Augmented-Reality-Brillen selbst auszuprobieren und sich mit Kolleg*innen aus Forschung und Entwicklung über unsere KI-Lösungen und deren Expertise auszutauschen. Weiter zum Thema KI und Arzneimittelforschung ging es auf unserem Panel: Gemeinsam diskutierten Dr. Marion Zerlin, Geschäftsführerin Forschung & Entwicklung, Sanofi Deutschland, Prof. Dr. Jochen Maas, Mitglied des Aufsichtsrats von Sanofi und Mitglied der Initiative Gesundheitsindustrie Hessen, Christian Tidona, Managing Director, BioMed X Heidelberg, sowie Co-Founder und Vorsitzender Strategic Advisory Board BioRN Heidelberg, und Thomas Klabunde, Global Head of Translational Disease Modelling bei Sanofi, über die Perspektiven und Anwendungsmöglichkeiten von KI in der Arzneimittelforschung. Miriam Liebelt-Henn, Vice President Communications Germany, Switzerland, Austria, Sanofi Deutschland moderierte die Diskussionsrunde. Aufschlussreich, zukunftsorientiert und inspirierend – kurzgefasst unser Fazit zur Teilnahme beim #Digitalgipfel2024! Dies wäre zuletzt nicht möglich gewesen ohne die zahlreichen Besucher*innen, Panelteilnehmer*innen, Sanofi-Mitarbeitenden und Hessisches Ministerium für Digitalisierung und Innovation. Vielen Dank an alle für eine großartige Plattform, um Diskussionen und Partnerschaften zu fördern! #digitalgipfelhessen #DigitalesHessen #Forschung #Innovation #KünstlicheIntelligenz
-
BioMed X Institute hat dies direkt geteilt
Wie beschleunigen wir die Arzneimittelforschung bei Sanofi? – Mit #KI! Von der Idee bis zum fertigen Medikament vergehen circa zwölf Jahre. Mit Hilfe Künstlicher Intelligenz kann die Arzneimittelforschung bereits heute beschleunigt werden, um Patient*innen schneller Zugang zu innovativen Arzneimitteln zu verschaffen. Wie der Einsatz von KI funktioniert und die Chancen für Deutschland aussehen, diskutieren Dr. Marion Zerlin, Prof. Dr. Jochen Maas, Christian Tidona und Thomas Klabunde mit Miriam Liebelt-Henn beim diesjährigen #Digitalgipfel2024 der Bundesregierung und der hessischen Landesregierung in Frankfurt am Main. Beim Digitalgipfel dabei? Dann gern bei unserem Panel „Health X Tomorrow: KI in Forschung und Entwicklung – noch schneller zu innovativen Arzneimitteln“ am Dienstag, 22. Oktober, 12 bis 13 Uhr im Kap Europa, Ebene 1 vorbeischauen. #digitalgipfel #BioCampus #digitalgipfelhessen #DigitalesHessen #Forschung #Innovation #KünstlicheIntelligenz
-
We're #hiring a new Recruiting Manager in Heidelberg. Apply now if you are interested. Otherwise, it would be great if you could share this post with your network.
-
🎉 Successful conference participation!! 🎉 Mojca Frank Bertoncelj, Dr. Janine Lückgen, and Tamara Pfanner represented team #PTA from BioMed X Institute at the Human Cell Atlas general meeting 2024 in Milan, Italy! PTA’s research focuses on discovering novel pro-resolution and tissue-protective therapeutic targets in immune-mediated inflammatory diseases (IMIDs). In Milan, Janine and Tamara successfully presented their posters on building multiomics maps of the inflamed human joint and dissecting macrophage functions across human pathologies and perturbations. Just a few days later, Dr. Janine Lückgen pitched her idea about developing macrophage-based therapies for IMIDs at the #BioRNConference organized by BioRN Life Science Cluster Rhine-Neckar. Janine was one of the six selected speakers at the Young Scientists Pitch Competition, sponsored by Evotec, where she actively engaged the broad audience and mastered the pitch challenge. 🎉 Congratulations to team #PTA for such successful conference contributions! 🎉 Read more about team #PTA here: https://lnkd.in/eXD5ep4E
-
#WelcomeToBioMedX 💐 We are happy to welcome Aashritha Ramesh, our new research assistant in team NST – New Strategies to Engage #Neutrophils in Solid Tumors. 💐 She is originally from Tamil Nadu, India, and holds a master's degree in #Biomedical Engineering from The Johns Hopkins University. During her time at Johns Hopkins Medical Institute (JHMI), she worked as a research assistant in the Department of Pathology. Prior to that, she gained valuable experience as a cancer research intern at the Department of Rheumatology at Harvard Medical School, where she contributed to research for her bachelor's thesis. 💐 Welcome, Aashritha, and good luck! 💡Are you interested in #career opportunities at the interface between #academia and #industry? Take a look at the BioMed X Institute Career Space: https://bio.mx/career. Stefanie Bärthel
-
#WelcomeToBioMedX 🌸We are happy to welcome Charu Sharma, our new intern in team PTA – Protective Tissue Factor in #Autoimmune Diseases. 🌸Charu is originally from #India, where she completed her bachelor’s degree in #Zoology from Delhi University. She is a master’s student in the Heidelberg University, and her focus is Molecular Biosciences, specializing in Molecular and Cellular Biology. Before joining BioMed X Institute, she gained research experience at DKFZ German Cancer Research Center, focusing on #single-cell spatial metabolic profiling. 🌸Welcome, Charu, and good luck! 💡Are you interested in #career opportunities at the interface between #academia and #industry? Take a look at the @BioMed X Institute Career Space: https://bio.mx/career. Mojca Frank Bertoncelj